» Articles » PMID: 29296259

New Hopes for Treatment of Alzheimer's Disease

Overview
Date 2018 Jan 4
PMID 29296259
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer's disease.

Mumtaz I, Ayaz M, Khan M, Manzoor U, Ganayee M, Bhat A Front Aging Neurosci. 2022; 14:977411.

PMID: 36158539 PMC: 9490081. DOI: 10.3389/fnagi.2022.977411.


Copper Toxicity Links to Pathogenesis of Alzheimer's Disease and Therapeutics Approaches.

Ejaz H, Wang W, Lang M Int J Mol Sci. 2020; 21(20).

PMID: 33081348 PMC: 7589751. DOI: 10.3390/ijms21207660.

References
1.
Chitnis T, Weiner H . CNS inflammation and neurodegeneration. J Clin Invest. 2017; 127(10):3577-3587. PMC: 5617655. DOI: 10.1172/JCI90609. View

2.
Akhondzadeh S . Hippocampal synaptic plasticity and cognition. J Clin Pharm Ther. 1999; 24(4):241-8. DOI: 10.1046/j.1365-2710.1999.00231.x. View

3.
Bhardwaj D, Mitra C, Aluganti Narasimhulu C, Riad A, Doomra M, Parthasarathy S . Alzheimer's Disease-Current Status and Future Directions. J Med Food. 2017; 20(12):1141-1151. DOI: 10.1089/jmf.2017.0093. View

4.
Akhondzadeh S . The 5-HT hypothesis of schizophrenia. IDrugs. 2005; 4(3):295-300. View

5.
Farokhnia M, Shafiee Sabet M, Iranpour N, Gougol A, Yekehtaz H, Alimardani R . Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial. Hum Psychopharmacol. 2014; 29(4):351-9. DOI: 10.1002/hup.2412. View